 |
NHS England will routinely fund Kadcyla for people with advanced HER-2 positive cancer Related items from OnMedica Ovarian cancer drug may help stall breast cancer The medicine price debate Breast cancer drug ‘too costly’ for NHS Experts recommend anastrozole for postmenopausal women with family history of breast cancer Cancer-preventing drugs |
Friday, 16 June 2017
NICE set to approve trastuzumab emtansine for breast cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment